US › Healthcare

Metagenomi, Inc. Common Stock (MGX)

US · Healthcare · Biotechnology

$1.210.00%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$1.2M
Revenue YoY
-69.8%
Net profit
$-23.1M
Profit YoY
+7.9%
EPS
$-0.61
EPS estimate
$-0.55
Net margin
-1,847.7%

EPS came in at -0.61 against a street estimate of -0.55 — a miss of 10.9%.

Key statistics

Market cap
$44.8M
Forward P/E
0.0
P/B
0.33
Book value
$3.66
EPS (TTM)
$-2.29
52-week high
$3.95
52-week low
$1.13
50-day MA
$1.26
200-day MA
$1.59
Beta
0.70

Analyst view

Analysts rate Metagenomi, Inc. Common Stock a buy (6 buy, 1 hold, 0 sell out of 7) with an average price target of $7.67.

Shareholding

Insiders
18.96%
Institutions
19.53%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC2.81%
Renaissance Technologies Corp2.09%
Catalio Capital Management, LP1.41%
Peapod Lane Capital LLC1.39%
Two Sigma Investments LLC1.32%
Bridgeway Capital Management, LLC1.05%
Jacobs Levy Equity Management, Inc.1.02%
Geode Capital Management, LLC0.95%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Metagenomi, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.